SKYE
NASDAQ
$0.64
Skye Bioscience Inc (SKYE)
Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.33 (+1045.31%)
Market Cap
$21M
FCF 5Y CAGR
+47.13%
Beta (5Y)
1.49
Price Chart
Valuation
Market Cap$21M
P/S117.90
P/B2.42
Profitability
EBITDA-$58M
EPS-$1.77
Growth & Risk
EPS 5Y CAGR-21.69%
FCF 5Y CAGR+47.13%
Beta (5Y)1.49
Sharpe Ratio-1.06